Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BREXPIPRAZOLE vs BRIGATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BREXPIPRAZOLE vs BRIGATINIB: Safety Overview

Metric BREXPIPRAZOLE BRIGATINIB
Total FAERS Reports 13,270 3,286
Deaths Reported 673 729
Death Rate 5.1% 22.2%
Hospitalizations 1,269 912
Average Patient Age 50.5 yrs 61.2 yrs
% Female Patients 69.0% 57.3%
FDA Approval Date Aug 11, 2022 Apr 28, 2017
Manufacturer Otsuka America Pharmaceutical, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription